Advances in mRNA design continue to shape the next generation of therapeutic development. Yet, achieving strong and sustained protein expression remains a persistent challenge across platforms.
DÜSSELDORF, Germany, Sept. 3, 2025 /PRNewswire/ -- LenioBio GmbH today announced a strategic partnership with AffinityAI, a Danish start-up pioneering AI-driven protein design. This collaboration ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する